EGCG Effect on the Expression of Bcl-2/Bax in Spiral Ganglion Neuron of the Rat Induced by Amikacin

LIU Qiang-he,XIE Ding-hua,YANG Xin-ming,WU Wei-jing
DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.18.017
2008-01-01
Abstract:[Objective] To study the expression of Bcl-2/Bax in Amikacin (Amk)-induced spiral ganglion neuron(SGN) apoptosis in the rat cochlea and the protection of (-)-epigallocatechin-3-gallate(EGCG). [Methods] All animals were divided into three groups: one group serving as the saline control group, one group receiving Amk at 450 mg/kg once a day for 14 days, one group receiving Amk plus EGCG at 50 mg/kg once a day for 14 days. Following deep anesthesia, the animals were half-body perfused intracardially with 4% paraformaldehyde (PFD), and the bullas were harvested, fixed in PFD, and decalcified in ethylenediamine tetraacetic acid (EDTA). After decalcification, the cochlea were embedded in paraffin, and cut in a paramodiolar plane subsequently. The immunohistochemical changes were observed for detecting with Bcl-2/Bax. [Results] The positive reaction for Bcl-2 and Bax staining was found in the cytoplasm of the SGN in the control group, and the positive staining could be detected differently in the group receiving Amk or the group receiving Amk plus EGCG. The image analysis showed the downregulation expression of Bcl-2 in the group receiving Amk, which was suppressed by EGCG. However, the upregulation expression of Bax was showed in the group receiving Amk, and suppressed by EGCG. [Conclusions] Bcl-2 and Bax were involved in Amk-induced oxidative damages to the SGN in the rat cochlea. EGCG effectively attenuated Amk-induced ototoxicity and suppressed Amk-induced SGN apoptosis by the influence on the expression of Bcl-2 and Bax.
What problem does this paper attempt to address?